Complete Heart Block

• AV Node-Level Block (Proximal Conduction Disease): In this category, the block occurs within the AV node itself, typically proximal to the bundle of His. Anatomically, the AV node receives dual blood supply (from both left and right coronary arteries), which provides some redundancy; however, during acute inferior myocardial infarction with right coronary artery occlusion, ischemia selectively damages the compact AV node. At the cellular level, ischemia increases intracellular calcium, reduces ATP availability, and impairs the function of calcium and potassium channels critical for nodal conduction. When AV nodal block occurs, an escape rhythm typically originates from the bundle of His or upper bundle branches and maintains a junctional escape rhythm with a QRS duration of 80-120 ms. This escape rhythm, while narrow-complex, is typically unreliable (rates often 40-60 bpm) during acute AV node ischemia because the subsidiary pacemakers in the proximal conduction system are themselves affected by ischemia. Critically, this type of block may be transient and reversible if coronary reperfusion occurs within hours, as demonstrated in acute MI studies showing restoration of AV conduction in 60-80% of inferior MI cases with reperfusion therapy.

• Infranodal Block (Distal Conduction Disease): In contrast, when the block is infranodal (in the bundle of His, bundle branches, or more distally), the escape rhythm originates from ventricular myocardium and produces a wide-complex (QRS >120 ms) ventricular escape rhythm at rates of 20-50 bpm. This occurs because ventricular myocardial conduction is slower than specialized conduction tissue, requiring depolarization to spread cell-to-cell without the benefit of Purkinje fibers. Importantly, infranodal block is almost always irreversible because it reflects structural damage to the conduction system—either ischemic necrosis during acute anterior myocardial infarction (caused by left anterior descending coronary artery occlusion affecting the bundle branches), degenerative fibrosis in chronic Lenegre disease, or infiltrative/inflammatory processes. In infranodal block, the subsidiary escape rhythm is inherently unreliable and prone to further slowing or sudden failure because ventricular pacemakers have intrinsically lower automaticity than nodal pacemakers. This distinction is crucial: proximal (nodal) block may be reversible with good prognosis; distal (infranodal) block is typically irreversible and requires permanent pacing.

• Hemodynamic Consequences and Compensatory Mechanisms: Regardless of block level, the immediate physiological consequence is loss of the normal atrial "kick," which normally contributes 15-30% of ventricular filling, particularly in conditions of diastolic dysfunction or increased ventricular stiffness. With complete loss of AV synchrony, ventricular filling depends entirely on passive diastolic filling without the booster effect of atrial contraction. The escape rhythm, whether junctional or ventricular, is slow and fixed at the intrinsic rate of the escape pacemaker—typically 40-60 bpm for junctional rhythms and 20-50 bpm for ventricular rhythms. This inadequate rate cannot increase appropriately in response to increased metabolic demands (exercise, sepsis, hypovolemia), resulting in chronotropic incompetence. Cardiac output falls precipitously because CO = stroke volume × heart rate; with diminished stroke volume (from loss of atrial kick) and inadequate rate increase, tissue perfusion becomes critically compromised. In acute presentations, hypotension ensues, cerebral perfusion pressure drops, and the patient may experience syncope or presyncope from transient cerebral hypoperfusion. The baroreceptor reflex attempts to compensate by increasing peripheral vascular resistance and contractility, but these responses are insufficient to maintain adequate tissue perfusion long-term.

• Chronotropic Incompetence and Rate-Adaptive Dysfunction: A critical physiological principle in complete heart block is that the escape rhythm is rate-fixed and does not increase with sympathetic stimulation (catecholamines, exercise, stress). In normal hearts, the sinus node responds to beta-adrenergic stimulation by increasing rate through increased L-type calcium channel activity and augmented automaticity. In contrast, ventricular escape pacemakers lack robust beta-adrenergic responsiveness, remaining refractory to catecholamine-driven rate acceleration. This phenomenon, termed chronotropic incompetence, means patients cannot physiologically increase cardiac output by increasing heart rate during periods of demand, a particularly important limitation during exercise, infection, or other stress states. This drives the rationale for rate-adaptive pacemaker programming in patients with complete heart block.

• Structural and Degenerative Mechanisms in Chronic Block: In chronic, non-ischemic causes such as Lenegre disease (progressive idiopathic fibrosis of the conduction system) or Lev disease (fibrosis related to aortic and mitral valve calcification), the pathological process involves gradual replacement of conduction tissue with fibrous collagen. Genetic factors contribute to Lenegre disease through mutations in genes encoding structural proteins (such as those affecting desmosomal proteins). Over months to years, these fibrotic changes create areas of scar tissue with markedly slowed conduction or complete block. Such changes are invariably irreversible and mandate permanent pacing once conduction block becomes manifest.

• Acute Myocardial Infarction (Most Common Acute Cause): Acute MI remains the most common cause of acquired complete heart block in clinical practice. The presentation and mechanism depend critically on the infarct location. Inferior myocardial infarction (typically from right coronary artery occlusion) causes AV nodal ischemia and produces high-degree or complete AV block in 1-2% of cases; this block is usually transient (lasting hours to days) and reversible with reperfusion, often resolving spontaneously or with restoration of coronary blood flow via percutaneous coronary intervention (PCI). Mechanistically, right coronary artery occlusion interrupts blood supply to the AV node (which receives 60% of its blood supply from the AV nodal artery, a branch of the RCA). In contrast, anterior myocardial infarction (from left anterior descending coronary artery occlusion) causes bundle branch block and infranodal complete heart block in 1-5% of cases; this block is typically irreversible because it reflects necrosis of the proximal bundle branches and is associated with extensive myocardial damage, large infarct size, and high mortality (up to 50% hospital mortality). The block in anterior MI often appears abruptly after initial bundle branch block, reflecting acute loss of remaining viable conduction tissue, and requires immediate temporary and then permanent pacing.

• Degenerative/Idiopathic Conduction System Disease: Lenegre disease represents progressive, age-related fibrosis of the conduction system—particularly the bundle branches—in the absence of associated cardiac structural disease. It is characterized by histological fibrosis and sclerosis of the conduction system and accounts for approximately 10-15% of complete heart block cases in the elderly population. Lev disease is similar but occurs in the context of calcific aortic valve disease, aortic sclerosis, and mitral annular calcification, with the fibrotic process extending into the adjacent conduction system. Both are irreversible and mandate permanent pacing once complete block develops.

• Post-Procedural/Post-Surgical Block: Complete heart block occurring within hours to days following cardiac surgery (particularly aortic valve replacement, mitral valve surgery, or septal myectomy) results from mechanical trauma to the bundle of His or bundle branches during surgical manipulation. The incidence is 0.5-2% depending on the procedure type and surgeon experience. The block may be transient (resolving within 3-7 days as edema subsides) or permanent (if the conduction tissue is irreparably damaged or resected). Transcatheter procedures, particularly transcatheter aortic valve implantation (TAVI) and ablation procedures, carry similar risk, with TAVI having an incidence of 3-6% of post-procedure complete heart block, particularly in cases with small aortic annuli or balloons used for implantation. In these settings, temporary transvenous pacing should be initiated immediately, and the decision to place a permanent pacemaker depends on the durability of block (typically determined by observing whether the block resolves within 3-7 days).

• Infiltrative and Inflammatory Diseases: Cardiac sarcoidosis can cause complete heart block through granulomatous infiltration of the basal septum and conduction system; it accounts for 5-10% of complete heart block cases in younger patients and is an important cause to recognize because immunosuppressive therapy (corticosteroids, immunosuppressants) may improve conduction in early disease. Lyme disease, caused by Borrelia burgdorferi infection transmitted by Ixodes tick vectors, characteristically presents with AV block (ranging from first-degree to complete heart block) in 5-10% of infected patients during the acute phase; the block typically resolves with antibiotic therapy (penicillin G or ceftriaxone). Chagas disease (Trypanosoma cruzi infection, endemic in Central and South America) causes chronic progressive destructive inflammation of the myocardium and conduction system, leading to various conduction abnormalities and complete heart block in advanced disease. Tuberculosis, fungal infections (particularly Coccidioides and Histoplasma in endemic regions), and leprosy (in endemic areas) can cause granulomatous infiltration of the myocardium and conduction system. Systemic lupus erythematosus (SLE) and Sjögren syndrome can cause conduction disease through autoimmune-mediated inflammation, with anti-Ro/SSA and anti-La/SSB antibodies implicated in neonatal lupus syndrome (discussed separately below). Giant cell myocarditis, a rare inflammatory condition of unknown etiology, presents with fulminant myocarditis, arrhythmias (including complete heart block), and cardiogenic shock, requiring aggressive immunosuppression and mechanical circulatory support.

• Infiltrative Cardiomyopathies: Cardiac amyloidosis (both light-chain amyloidosis [AL amyloidosis] and transthyretin [ATTR] amyloidosis) can deposit amyloid fibrils in the myocardium and conduction system, causing restrictive cardiomyopathy and conduction system disease including complete heart block. Hemochromatosis with secondary cardiac iron overload causes restrictive or dilated cardiomyopathy and may damage the conduction system. Fabry disease (α-galactosidase A deficiency) produces cardiac involvement including arrhythmias and conduction disease.

• Congenital Complete Heart Block (Neonatal Lupus Syndrome): Maternal anti-Ro/SSA and anti-La/SSB antibodies (found in mothers with SLE or Sjögren syndrome) cross the placenta and target cardiac myosin light chains and ribonucleoproteins in the fetal heart, causing inflammation and fibrosis of the AV node and conduction system. This results in congenital complete heart block presenting prenatally (detected on fetal echocardiography as complete dissociation of atrial and ventricular rates) or in the neonatal period. Importantly, approximately 2-3% of pregnancies in anti-Ro/SSA-positive mothers result in neonatal lupus syndrome with congenital heart block. Maternal treatment with steroids and/or intravenous immunoglobulin during pregnancy may prevent progression of incomplete to complete block. Neonates with congenital complete heart block require pacemaker implantation if the ventricular escape rate is inadequate (<50 bpm) or if hemodynamic compromise is present.

• Medications and Toxins: While less commonly causing complete heart block, several drugs can produce high-degree or complete AV block, particularly in susceptible individuals with baseline conduction system disease: digitalis (through enhanced vagal tone and direct AV nodal depression), beta-blockers, calcium channel blockers (particularly verapamil and diltiazem), and antiarrhythmic drugs (class I and III agents, particularly flecainide, sotalol, and amiodarone). Lithium can cause conduction system disease. These typically produce incomplete block rather than complete block but are worth considering in the clinical context.

• Trauma and Infiltration: Cardiac trauma (penetrating or blunt) can acutely damage the conduction system. Radiation therapy to the chest (for lymphoma, breast cancer, or other malignancies) can cause long-term radiation-induced conduction system disease and cardiomyopathy. Metastatic malignancy involving the myocardium is rare but possible.

• Other Causes: Myxedema (hypothyroidism) occasionally worsens pre-existing conduction disease. Hyperkalemia can produce AV block as part of its effects on cardiac electrophysiology (though it more typically causes peaked T-waves and widened QRS complexes). Aneurysmal subarachnoid hemorrhage can produce temporary AV block through catecholamine surge and sympathetic nervous system activation.

• Syncope and Presyncope: These are the hallmark presenting symptoms of complete heart block and result from the acute drop in cardiac output and cerebral perfusion pressure when AV conduction is lost. In acute-onset complete heart block, particularly if the escape rhythm has not yet emerged or if the escape rhythm is unreliably slow, cerebral perfusion becomes critically inadequate. Syncope may occur suddenly without warning (hence the term "Stokes-Adams attack," historically applied to syncope in the setting of complete heart block). Presyncope manifests as lightheadedness, dizziness, or a sense of impending loss of consciousness. Some patients report prodromal symptoms (palpitations from cannon A waves, described below) just before syncope. Notably, complete heart block can cause sudden cardiac death if the escape rhythm fails entirely or if the interval between loss of AV conduction and emergence of an escape rhythm is prolonged (the "cardiac standstill" phenomenon). In some cases, patients may have had brief episodes of syncope or near-syncope before diagnosis, attributed to other causes.

• Dyspnea: Dyspnea results from pulmonary venous congestion secondary to inadequate cardiac output and compensatory diastolic dysfunction. The loss of the atrial contribution to ventricular filling (normally 15-30% of stroke volume) reduces diastolic filling, particularly in ventricles with baseline diastolic dysfunction or increased stiffness. Additionally, the fixed, slow escape rhythm cannot increase with exertion, preventing adequate increase in cardiac output during activity. Dyspnea is typically exertional (worse with activity when demand for cardiac output increases), and patients may report orthopnea or paroxysmal nocturnal dyspnea if there is concurrent left ventricular dysfunction. In acute presentations with severe bradycardia and low cardiac output, dyspnea may be accompanied by signs

Initial test — the 12-lead ECG

• 12-lead ECG with a long rhythm strip is the first and usually definitive test. The diagnostic finding is complete AV dissociation: P waves march out at a regular P–P interval, QRS complexes march out at a regular but slower R–R interval, and the PR interval varies randomly with no P wave consistently conducting. The atrial rate exceeds the ventricular rate — this is what separates complete heart block from isolated AV dissociation due to an accelerated junctional/ventricular rhythm, where the ventricular rate is the faster one.
• Escape QRS width localizes the block: a narrow QRS (junctional escape, ~40–60 bpm) implies AV-nodal/proximal block; a wide QRS (>120 ms, ventricular escape, ~20–40 bpm) implies infranodal disease and an unstable escape. This distinction drives prognosis and urgency.
• P waves buried in T waves are a classic reading trap — calipers marching out the P–P interval reveal the hidden atrial activity.

Confirming the cause and level

• Continuous telemetry in all acutely symptomatic patients; ambulatory/event monitoring or an implantable loop recorder for intermittent block presenting as unexplained syncope, as endorsed by the ACC/AHA/HRS 2018 bradycardia and conduction delay guideline.
• Reversible-cause workup: potassium, magnesium, calcium, TSH, digoxin level, troponin, and Borrelia burgdorferi serology in endemic exposure. Review every AV-nodal blocking drug.
• Echocardiography to assess LV function, valve calcification (Lev disease), wall thickening suggesting infiltration, and to guide device selection.
• Advanced imaging — cardiac MRI or FDG-PET — when sarcoidosis, amyloidosis, or myocarditis is suspected, particularly in a young patient with new block.
• Electrophysiology study with His-bundle recording is the gold standard for localizing the block; a prolonged HV interval or block distal to the His deflection confirms infranodal disease. It is reserved for ambiguous cases, since surface ECG plus clinical context usually suffices.

Immediate stabilization (unstable patient — hypotension, altered mental status, ischemic chest pain, shock)

• Atropine, an antimuscarinic: 1 mg IV push, repeated every 3–5 minutes to a maximum of 3 mg, per the AHA adult bradycardia algorithm. It works only by withdrawing vagal tone at the AV node, so it may help nodal block but is typically ineffective in wide-complex infranodal block and can paradoxically worsen hemodynamics by accelerating the sinus rate without improving conduction. Do not delay pacing for it.
• Transcutaneous pacing: the immediate bridge in any unstable patient. Confirm electrical and mechanical capture (pulse, not just pacer spikes); it is painful and requires analgesia/sedation.
• Chronotropic infusions as an alternative bridge: beta-agonists such as dopamine (5–20 mcg/kg/min) or epinephrine (2–10 mcg/min); isoproterenol is an option, especially post-transplant or in torsades-prone bradycardia.

Reverse what is reversible before committing to a device

• Stop AV-nodal blockers (beta blockers, verapamil/diltiazem, digoxin, antiarrhythmics).
• Antidotes: calcium salts and high-dose insulin for calcium channel blocker toxicity, glucagon for beta blocker toxicity, digoxin immune Fab for digitalis toxicity.
• Treat hyperkalemia, myxedema, Lyme carditis (IV ceftriaxone for high-grade block, per IDSA/AAN/ACR Lyme disease guidance), and cardiac sarcoidosis (corticosteroids).
• Urgent reperfusion in acute MI — inferior MI block is usually nodal and transient and often resolves with PCI.

Complications of the block itself

• Ventricular asystole / sudden cardiac death (emergency): failure of an unreliable escape pacemaker produces cardiac standstill. Signalled by prolonged pauses on telemetry, recurrent Stokes-Adams syncope, or a wide-complex escape below ~40 bpm. Requires immediate pacing.
• Bradycardia/pause-dependent torsades de pointes (emergency): long diastolic intervals prolong repolarization and permit early afterdepolarizations. Look for a long QT with R-on-T ventricular ectopy. Treated with IV magnesium and overdrive pacing or isoproterenol — not with additional QT-prolonging antiarrhythmics.
• Cardiogenic shock and acute heart failure: fixed slow rate plus loss of the atrial kick collapses cardiac output; cool extremities, rising lactate, oliguria.
• Syncope-related trauma: head injury, fractures, and motor vehicle collisions — a major morbidity in undiagnosed intermittent block.

Complications of pacing therapy

• Cardiac perforation with tamponade (emergency): lead penetration through a thin RV wall; hypotension, pulsus paradoxus, loss of capture or diaphragmatic stimulation — obtain urgent echocardiography.
• Pneumothorax/hemothorax: from subclavian venous access; new dyspnea and hypoxia after implant.
• Lead dislodgement or failure to capture: pacer spikes without a following QRS; usually within the first weeks.
• Device infection and lead endocarditis (emergency): pocket erythema, erosion, or Staphylococcus aureus bacteremia. Sustained bacteremia with an intracardiac lead mandates complete system extraction plus antibiotics.
• Pacemaker syndrome: with single-chamber ventricular pacing, loss of AV synchrony and retrograde VA conduction cause cannon A waves, neck pulsation, fatigue, and hypotension; treated by upgrading to dual-chamber pacing.
• Pacing-induced cardiomyopathy: chronic high-burden RV apical pacing produces dyssynchronous, LBBB-like activation and a falling LVEF — the rationale in the ACC/AHA/HRS 2018 bradycardia guideline for resynchronization or conduction-system pacing.
• Other: tricuspid regurgitation from lead impingement, upper-extremity venous thrombosis, and painful skeletal muscle capture during transcutaneous pacing.

• The ECG signature: regular P–P, regular R–R, no relationship between them, and an atrial rate faster than the ventricular rate. If the ventricular rate is the faster one, it is AV dissociation from an accelerated junctional/ventricular rhythm — not complete heart block. This is the single most common distractor.
• Exam buzzwords: cannon A waves in the JVP, variable-intensity S1, and Stokes-Adams attacks (abrupt syncope without prodrome). Cannon A waves occur intermittently here, versus regular cannon A waves in a junctional rhythm.
• QRS width predicts the future: narrow escape = nodal, faster, catecholamine- and atropine-responsive, often reversible; wide escape = infranodal, slow, unreliable, and essentially always requires a permanent pacemaker.
• Best next step in an unstable patient is transcutaneous pacing — do not stall on repeat atropine doses in wide-complex block, where atropine typically fails.
• Infarct location is the classic association: inferior MI (RCA, AV nodal artery) → transient nodal block that resolves with reperfusion; anterior MI (LAD) → infranodal block signifying extensive septal necrosis, poor prognosis, permanent pacing.
• Always hunt for a reversible cause before implanting: hyperkalemia, digoxin/beta blocker/calcium channel blocker toxicity, hypothyroidism, and Lyme carditis. A young hiker with a bull's-eye rash and complete heart block gets IV ceftriaxone, not a pacemaker — block resolves with antibiotics.
• Congenital complete heart block in a neonate points to maternal anti-Ro/SSA (and anti-La/SSB) antibodies, often in an undiagnosed mother with SLE or Sjögren syndrome.
• In atrial fibrillation, a regularized slow ventricular response means complete heart block with a junctional escape — the classic clue to digoxin toxicity.
• Permanent pacing is a Class I indication for irreversible acquired complete heart block per the ACC/AHA/HRS 2018 bradycardia guideline, even when the patient is asymptomatic.